Max Lewandowski

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Tissue Engineering

Top Venues

Communications chemistry

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Max Lewandowski, Melania Carmina, Loris Knümann, Minh Sai, Sabine Willems, Till Kasch, Julius Pollinger, Stefan Knapp, Julian A Marschner, Apirat Chaikuad, Daniel Merk
Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties. Journal of medicinal chemistry 67 (3) (2024)
Minh Sai, Emily C Hank, Hin-Man Tai, Till Kasch, Max Lewandowski, Michelle Vincendeau, Julian A Marschner, Daniel Merk
Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing. Communications chemistry 7 (1) (2024)
Max Lewandowski, Melania Carmina, Loris Knümann, Minh Sai, Sabine Willems, Till Kasch, Julius Pollinger, Stefan Knapp, Julian A Marschner, Apirat Chaikuad, Daniel Merk
Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties. Journal of medicinal chemistry (2024)
Max Lewandowski, Melania Carmina, Loris Knümann, Minh Sai, Sabine Willems, Till Kasch, Julius Pollinger, Stefan Knapp, Julian A Marschner, Apirat Chaikuad, Daniel Merk
Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties. Journal of medicinal chemistry 67 (3) (2024)
Minh Sai, Emily C Hank, Hin-Man Tai, Till Kasch, Max Lewandowski, Michelle Vincendeau, Julian A Marschner, Daniel Merk
Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing. Communications chemistry 7 (1) (2024)
Minh Sai, Emily C Hank, Hin-Man Tai, Till Kasch, Max Lewandowski, Michelle Vincendeau, Julian A Marschner, Daniel Merk
Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing. Communications chemistry 7 (1) (2024)